insights_auto
Why is BEAM up 3.07%?
Dive Deeperchevron_right
BEAM:NASDAQ
Beam Therapeutics Inc
$24.19
arrow_upward
+3.07%(+0.72) 1D
$24.03
arrow_downward
-0.66% (-0.16)bedtimeAfter hours
Closed: Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Open
$23.88
High
$24.38
Low
$23.50
Mkt. cap
2.50B
Avg. vol.
2.00M
Volume
1.32M
52-wk high
$38.26
52-wk low
$20.23
EPS
-$0.81
Beta
2.20
Shares outstanding
103.29M
No. of employees
540
Open
$23.88
High
$24.38
Low
$23.50
Mkt. cap
2.50B
Avg. vol.
2.00M
Volume
1.32M
52-wk high
$38.26
52-wk low
$20.23
EPS
-$0.81
Beta
2.20
Shares outstanding
103.29M
No. of employees
540
News stories
From web sources and news partners
Investing.com Nigeria
·
2 days ago
Form 144 BEAM THERAPEUTICS INC. For: 17 October By Investing.com
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc